Correlation Between Allovir and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Allovir and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allovir and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allovir and Elevation Oncology, you can compare the effects of market volatilities on Allovir and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allovir with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allovir and Elevation Oncology.
Diversification Opportunities for Allovir and Elevation Oncology
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Allovir and Elevation is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Allovir and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Allovir is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allovir are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Allovir i.e., Allovir and Elevation Oncology go up and down completely randomly.
Pair Corralation between Allovir and Elevation Oncology
Given the investment horizon of 90 days Allovir is expected to under-perform the Elevation Oncology. In addition to that, Allovir is 1.44 times more volatile than Elevation Oncology. It trades about -0.04 of its total potential returns per unit of risk. Elevation Oncology is currently generating about 0.08 per unit of volatility. If you would invest 61.00 in Elevation Oncology on September 12, 2024 and sell it today you would earn a total of 11.00 from holding Elevation Oncology or generate 18.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allovir vs. Elevation Oncology
Performance |
| Timeline |
| Allovir |
| Elevation Oncology |
Allovir and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allovir and Elevation Oncology
The main advantage of trading using opposite Allovir and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allovir position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Allovir vs. Anebulo Pharmaceuticals | Allovir vs. Mineralys Therapeutics, Common | Allovir vs. AN2 Therapeutics | Allovir vs. Aerovate Therapeutics |
| Elevation Oncology vs. Puma Biotechnology | Elevation Oncology vs. Iovance Biotherapeutics | Elevation Oncology vs. Sarepta Therapeutics | Elevation Oncology vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |